These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2996654)

  • 21. [Comparison of the decurarizing and median lethal doses of 2-aminopyridine salts].
    Spasov V; Getova D; Spasov A
    Eksp Med Morfol; 1979; 18(2):98-101. PubMed ID: 467313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roads from vaccines to therapies.
    Smith LA; Jensen MJ; Montgomery VA; Brown DR; Ahmed SA; Smith TJ
    Mov Disord; 2004 Mar; 19 Suppl 8():S48-52. PubMed ID: 15027054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The strange case of the botulinum neurotoxin: using chemistry and biology to modulate the most deadly poison.
    Willis B; Eubanks LM; Dickerson TJ; Janda KD
    Angew Chem Int Ed Engl; 2008; 47(44):8360-79. PubMed ID: 18844202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect 4-aminopyridine on the recovery of segmental reflexes after sectioning of the sciatic nerve in the rat].
    Serdiuchenko IIa; Mantulo PM; Karneta IM
    Neirofiziologiia; 1986; 18(5):702-4. PubMed ID: 3022170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [First outbreak of botulism caused by Clostridium botulinum subtype Af].
    Fernández RA; Ciccarelli AS; Arenas GN; Giménez DF
    Rev Argent Microbiol; 1986; 18(1):29-31. PubMed ID: 3317514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synaptic facilitation by 3-aminopyridine and its antagonism by verapamil and diltiazem.
    Riker WK; Matsumoto M; Takashima K
    J Pharmacol Exp Ther; 1985 Nov; 235(2):431-5. PubMed ID: 2997434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of botulinum toxin on catecholamine concentration in different types of skeletal muscle].
    Chesnokova NP; Alaeva IV
    Vopr Med Khim; 1980; 26(6):813-7. PubMed ID: 7456413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The recombinant Hc subunit of Clostridium botulinum neurotoxin serotype A is an effective botulism vaccine candidate.
    Yu YZ; Li N; Zhu HQ; Wang RL; Du Y; Wang S; Yu WY; Sun ZW
    Vaccine; 2009 May; 27(21):2816-22. PubMed ID: 19428892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy.
    Durham PL; Cady R; Cady R
    Headache; 2004 Jan; 44(1):35-42; discussion 42-3. PubMed ID: 14979881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A new approach to the prevention and treatment of lesions caused by bacterial toxins: prospects for using inhibitors of ADP ribosylation].
    Krasil'nikov II; Stepanov AV; Misnikova MA
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (1):11-3. PubMed ID: 8820668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antidotal effect of 4-aminopyridine on acute poisoning induced by magnesium sulfate].
    Zheng W; Zhang YP; Fang RY
    Zhongguo Yao Li Xue Bao; 1986 Mar; 7(2):178-82. PubMed ID: 2946162
    [No Abstract]   [Full Text] [Related]  

  • 32. [The nonspecific mechanisms of the pharmacological correction of motoneuron trophic failure in experimental botulin poisoning].
    Mikhaĭlov VV; Mikhaĭlov VV
    Eksp Klin Farmakol; 1992; 55(6):46-8. PubMed ID: 1305877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of 4-aminopyridine in experimental CNS demyelination.
    Kaji R; Sumner AJ
    Neurology; 1988 Dec; 38(12):1884-7. PubMed ID: 2848207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Protective action of serotonin against botulinum neurotoxicity in the mouse].
    Tazieff-Depierre F; Desban M
    C R Seances Acad Sci D; 1979 Jan; 288(1):167-8. PubMed ID: 111823
    [No Abstract]   [Full Text] [Related]  

  • 35. 4-Aminopyridine and haemodialysis in the treatment of verapamil intoxication.
    ter Wee PM; Kremer Hovinga TK; Uges DR; van der Geest S
    Hum Toxicol; 1985 May; 4(3):327-9. PubMed ID: 2989157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of 4-aminopyridine in patients with multiple sclerosis.
    Jones RE; Heron JR; Foster DH; Snelgar RS; Mason RJ
    J Neurol Sci; 1983; 60(3):353-62. PubMed ID: 6631441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antagonism of the ruthenium red-induced paralysis in mice by 4-aminopyridine, guanidine and lanthanum.
    Tapia R
    Neurosci Lett; 1982 May; 30(1):73-7. PubMed ID: 6179018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of effect of 4-aminopyridine on choreic movements.
    Lundh H; Fehling C
    J Neurol Neurosurg Psychiatry; 1982 Mar; 45(3):274-5. PubMed ID: 6211524
    [No Abstract]   [Full Text] [Related]  

  • 39. Electromyographic findings in experimental botulinum intoxication.
    JOSEFSSON JO; THESLEFF S
    Acta Physiol Scand; 1961; 51():163-8. PubMed ID: 13790734
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of tricyanoaminopropene upon mice poisoned with botulinus toxin.
    Stern P; Boras J
    Toxicon; 1968 Feb; 5(3):187-90. PubMed ID: 5640301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.